Accorded Acumen revolutionizes healthcare actuarial analytics, making it faster and more accessible for all risk-bearing organizations.

In concert with their rebrand, Accorded is launching Contract Designer, a business application for healthcare stakeholders to leverage financial forecasts to dynamically design and compare value-based contract terms. Contract Designer facilitates seamless collaboration between providers and payers with in-app proposal delivery and contract addendum generation. This is the first to market solution of its kind for value-based contract design and collaboration.

SALT LAKE CITY, COPPELL, Texas and SAN MATEO, Calif., Oct. 4, 2022 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, Sonrava Health, a national family of health and wellness companies, and Cerebrae, an innovator in pricing and measuring the financial value of care, are collaborating to provide Sera's PreTRM® Test to members of Sonrava Health's employer-sponsored health insurance program. The PreTRM® Test is the only broadly clinically validated, commercially available blood test that provides an early, individual risk assessment for spontaneous preterm birth in asymptomatic, singleton pregnancies. Sera's PreTRM® Test identifies nearly 90% of pregnancies where spontaneous preterm deliveries will occur, enabling earlier proactive intervention designed to improve the well-being of mothers and babies.